Sibylla Biotech and MD Anderson Agree to Jointly Discover and Develop Small-Molecule Protein Degraders
Sibylla Biotech and the University of Texas MD Anderson Cancer Center entered into a strategic collaboration agreement to discover and develop novel small-molecule cancer therapies—Folding Interfering Degrader…
Read guide →